Authorised

Product identification

Medicine name:
Rabisin
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Cattle
  • Sheep
  • Horse
  • Other Mammals
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    0.00
    milligram(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Sheep
      • Meat and offal
        0
        day
    • Horse
    • Other Mammals
  • Subcutaneous use
    • Cattle
    • Dog
    • Cat
    • Other Mammals
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 1 bottle
  • Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 10 bottles
  • Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 100 bottles

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/074/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/03/2023
Download
Source URL: https://medicines.health.europa.eu/veterinary/600000080509